BioSpace News Archive

AIVITA Biomedical, Inc. announced that chairman and CEO Dr. Hans S. Keirstead will deliver an opening keynote at the World Immunotherapy Congress Europe, a submeeting of the Festival of Biologics Europe taking place Nov 2-4 in Basel, Switzerland.

InMode Ltd., a leading global provider of innovative medical technologies, announced that InMode will present at the following investor conferences in November.

Dragonfly Therapeutics, Inc. (“Dragonfly”), today announced that the first patient has been dosed in a clinical trial being conducted by Merck, known as MSD outside the United States and Canada, to evaluate a solid tumor targeting TriNKET developed by Dragonfly.

KaliVir Immunotherapeutics, Inc. announced the appointment of Adina Pelusio, M.S., as Senior Vice President of Clinical Operations.

Blueprint Medicines (NASDAQ: BPMC) today announced its 2027 Blueprint to achieve precision medicine at scale, a five-year business strategy to expand the company’s reach to broader patient populations by leveraging its scientific leadership, proven development capability and integrated business.

Insmed Incorporated today announced that management will present at the following investor conferences.

Marpai, Inc. (“Marpai” or the “Company”) (Nasdaq: MRAI), a deep learning technology company transforming third-party administration (TPA) in the self-funded health insurance market, will host a conference call and webcast on Thursday, November 10 at 8:30 a.m. ET to answer questions about the Company’s operational and financial highlights for its third quarter in 2022.

Freenome announced 50 hospitals and community oncology practices across the United States have joined as clinical partners for its Vallania Study.

Amyris, Inc. today announced that it will issue its financial results for the third quarter ended September 30, 2022, on the afternoon of Tuesday, November 8, 2022, after closing of the financial markets.

Acurx Pharmaceuticals, Inc. announced today that the Company will release its 2022 third quarter financial results on Monday, November 14, 2022, at 8:30 am ET before the U.S. financial markets open.